Table 1.
Baseline characteristics
|
Case
Group (n = 26) |
Placebo control group
(n = 30) |
|
|---|---|---|
| Women (n) | 21 | 19 |
| Men (n) | 5 | 11 |
| Age (year) | 42.19 ± 11.52 | 43.60 ± 9.05 |
| Weight (kg) | 80.63 ± 11.65 | 79.30 ± 16.43 |
| Height (cm) | 161.65 ± 9.53 | 161.90 ± 7.30 |
| WC (cm) | 105.76 ± 9.01 | 103.36 ± 12.09 |
| HC (cm) | 115.61 ± 9.49 | 112.60 ± 10.89 |
| Smokers % (n) | 11.5(2) | 10(2) |
| Diabetics % (n) | 23(5) | 20(4) |
| Hypertensive % (n) | 23(5) | 23.3(5) |
| Dyslipide mic % (n) | 23(5) | 23.3(5) |
| Triglycerides (mg/dl) | 139.76 ±70.14 | 139.00 ± 73.52 |
| Total cholesterol (mg/dl) | 214.15 ±27.30 | 227.16 ± 33.34 |
| HDL-C ( mg/dl) | 39.03 ± 5.34 | 39.13 ± 8.00 |
| LDL-C (mg/dl) | 120.03 ± 30.01 | 125.16 ± 22.33 |
| FBS (mg/dl) | 109.69 ± 24.02 | 108.33 ± 22.26 |
| SBP (mmHg) | 117.3 ± 1.04 | 116.1 ± 0.94 |
| DBP (mmHg) | 76.9 ± 1.04 | 77.8 ± 1.09 |